Literature DB >> 32067060

Five-year survival of patients in control groups of randomized controlled trials is much higher than that assumed in observational study reports.

Misel Milosevic1, John Edwards2, Joel Dunning3, Michael Shackcloth4, Tom Treasure5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32067060     DOI： 10.1007/s00384-020-03540-y

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  6 in total

1.  Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

Authors:  T Ruers; C Punt; F Van Coevorden; J P E N Pierie; I Borel-Rinkes; J A Ledermann; G Poston; W Bechstein; M A Lentz; M Mauer; E Van Cutsem; M P Lutz; B Nordlinger
Journal:  Ann Oncol       Date:  2012-03-19       Impact factor: 32.976

2.  Lung metastasectomy after colorectal cancer: prognostic impact of resection margin on long term survival, a retrospective cohort study.

Authors:  Federico Davini; Sara Ricciardi; Carmelina C Zirafa; Gaetano Romano; Greta Alì; Gabriella Fontanini; Franca M A Melfi
Journal:  Int J Colorectal Dis       Date:  2019-11-04       Impact factor: 2.571

3.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

Review 4.  Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis.

Authors:  Michel Gonzalez; Antoine Poncet; Christophe Combescure; John Robert; Hans Beat Ris; Pascal Gervaz
Journal:  Ann Surg Oncol       Date:  2012-10-28       Impact factor: 5.344

5.  The effect of metastasectomy: fact or fiction?

Authors:  T Aberg; K A Malmberg; B Nilsson; E Nöu
Journal:  Ann Thorac Surg       Date:  1980-10       Impact factor: 4.330

6.  Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial.

Authors:  Tom Treasure; Vern Farewell; Fergus Macbeth; Kathryn Monson; Norman R Williams; Chris Brew-Graves; Belinda Lees; Olivia Grigg; Lesley Fallowfield
Journal:  Trials       Date:  2019-12-12       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.